Compare IRM & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRM | ZTS |
|---|---|---|
| Founded | 1951 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.0B | 31.2B |
| IPO Year | 1997 | 2012 |
| Metric | IRM | ZTS |
|---|---|---|
| Price | $126.31 | $81.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $122.50 | ★ $154.18 |
| AVG Volume (30 Days) | 1.5M | ★ 7.7M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.02% | 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | 0.48 | ★ 1.42 |
| Revenue | $4,491,531,000.00 | ★ $9,467,000,000.00 |
| Revenue This Year | $13.30 | $5.63 |
| Revenue Next Year | $9.31 | $4.77 |
| P/E Ratio | $264.17 | ★ $56.30 |
| Revenue Growth | ★ 8.30 | 2.28 |
| 52 Week Low | $77.77 | $73.82 |
| 52 Week High | $134.09 | $172.23 |
| Indicator | IRM | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 58.26 | 28.89 |
| Support Level | $98.60 | $73.82 |
| Resistance Level | $134.09 | $129.32 |
| Average True Range (ATR) | 3.26 | 3.79 |
| MACD | -0.78 | -0.25 |
| Stochastic Oscillator | 36.54 | 18.07 |
Iron Mountain Inc is an information management services provider organized and operated as a real estate investment trust. The company offers solutions to its clients to address their information management, digital transformation, information security, data center, and asset lifecycle management (ALM) needs. Its customers come from various industries, including commercial, legal, financial, healthcare, technology, etc. The company has two reportable segments: Global Records and Information Management (Global RIM) and Global Data Center. Maximum revenue is generated from the Global RIM segment, which offers data and records management, secure shredding, consumer storage, and other related services. Geographically, the company generates maximum revenue from the United States.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.